Terns Pharmaceuticals, Inc. (TERN) Tops Q2 EPS by 8c

Terns Pharmaceuticals, Inc. (NASDAQ: TERN) reported Q2 EPS of ($0.25), $0.08 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Terns Pharmaceuticals, Inc. (TERN) click here.

You May Also Be Interested In

• Wall Street on Fed rate hike: 'As hawkish as it gets'
• CoreWeave signs new compute contracts at $40M per megawatt pricing
• Oscar Health Inc (OSCR) PT Raised to $48 at Piper Sandler